Environmental challenges for nanomedicine

Nanomedicine

Volumn 3, Issue 5, 2008, Pages 605-608

  Baun, Anders ^a   Hansen, Steffen Foss ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON NANOTUBE; NANOPARTICLE; QUANTUM DOT;

CONCENTRATION (PARAMETERS); ECOTOXICITY; EDITORIAL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT; ENVIRONMENTAL PROTECTION; HUMAN; NANOENGINEERING; NANOMEDICINE; NANOTECHNOLOGY; NANOTOXICOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; WATER POLLUTION; CHEMISTRY; DRUG DESIGN; ECOLOGY; ENVIRONMENT; LEGAL ASPECT; METHODOLOGY; POLLUTANT; RISK;

DRUG DESIGN; ECOLOGY; ENVIRONMENT; ENVIRONMENTAL POLLUTANTS; HUMANS; NANOMEDICINE; NANOTECHNOLOGY; NANOTUBES, CARBON; QUANTUM DOTS; RISK; RISK ASSESSMENT;

EID: 55949131568     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/17435889.3.5.605     Document Type: Editorial

References (20)

1. Hansen SF, Larsen BH, Olsen SI, Baun A: Categorization framework to aid hazard identification of nanomaterials. Nanotoxicology 1, 243-250 (2007).
2. Linkov I, Satterstrom FK, Corey LM: Nanotoxicology and nanomedicine: making hard decisions. Nanomedicine 4, 167-171 (2008).
3. Fent K, Weston AA, Caminada D: Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 76(2), 122-159 (2006).
4. Zuccato E, Castiglioni S, Fanelli R et al.: Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control. Environ. Sci. Pollut. Res. Int. 13(1), 15-21 (2006).
5. Heberer T: Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett. 131(1-2), 5-17 (2002).
6. Huschek G, Hansen PD, Maurer HH, Krengel D, Kayser A: Environmental risk assessment of medicinal products for human use according to European commission recommendations. Environ. Toxicol. 19(3), 226-240 (2004).
7. Hansen SF, Maynard A, Baun A, Tickner JA: Late lessons from early warnings for nanotechnology. Nat. Nanotechnol. 3(8), 444-447 (2008).
8. Zhang X, Sun H, Zhang Z, Niu Q, Chen Y, Crittenden JC: Enhanced bioaccumulation of cadmium in carp in the presence of titanium dioxide nanoparticles. Chemosphere 67, 160-166 (2007).
9. Baun A, Sørensen SN, Rasmussen RF, Hartmann NB, Koch CB: Toxicity and bioaccumulation of xenobiotic organic compounds in the presence a aqueous suspensions of aggregates of nano-C60. Aquat. Toxicol. 86, 379-387 (2008).
10. US Food and Drug Administration: Guidance for industry for submission of an environmental assessment in human drug applications and supplements. CMC, 6 July, Revision 1. Office of Training and Communications, Rockville, MD, USA (1998).
11. European Medicines Agency: Guideline on the environmental risk assessment of medicinal products for human use EMEA/CHMP/SWP/4447/00. European Medicines Agency, London, UK (2006).
12. Handy RD, Owen R, Valsami-Jones E: The ecotoxicology of nanoparticles and nanomaterials: current status, knowledge gaps, challenges, and future needs. Ecotoxicology 17(5), 315-25 (2008).
13. Baun A, Hartmann NB, Grieger K, Kusk KO: Ecotoxicity of engineered nanoparticles to aquatic invertebrates: a brief review and recommendations for future toxicity testing. Ecotoxicology 17(5), 387-395 (2008).
14. Oberdörster G, Maynard A, Donaldson K et al.: Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part. Fibre Toxicol. 2(8), 1-35 (2005).
15. Scientific Committee for Emerging and Newly Identified Health Risks (SCENIHR): The appropriateness of the risk assessment methodology in accordance with the Technical Guidance Documents for new and existing substances for assessing the risks of nanomaterials. European Commission, Brussels, Belgium (2007).
16. Tickner JA: Why Risk Assessment is Not Enough to Protect Health: Rationale for a Precautionary Approach to Science and Policy. In: Risk Assessment fo Environmental Health. Robson M, Toscano W (Eds). John Wiley & Sons, San Francisco, CA, USA 423-462 (2007).
17. Owen R, Handy R: Formulating the problems for environmental risk assessment of nanomaterials. Environ. Sci. Technol. 41(16), 5582-5588 (2007).
18. Maynard AD, Aitken RJ: Assessing exposure to airborne nanomaterials: Current abilities and future requirements. Nanotoxicology 1 (1), 26-41 (2007).
19. OECD Working Party on Manufactured Nanomaterials: List of manufactured nanomaterials and list of endpoints for phase one of the OECD testing programme. OECD Environment, Health and Safety Publications, Series on the safety of manufactured nanomaterials. No. 6. Environment Directorate, Organisaton for Economic Co-Operation and Development, Paris, France (2008).
20. US Environmental Protection Agency: Nanotechnology White Paper Science Policy Council. US Environmental Protection Agency; Washington, DC, USA (2007).